Catheter Precision, Inc.
VTAKdata completeness 100%9 fiscal years on fileCatheter Precision, Inc. earns about -197% on invested capital, but has diluted owners by 970% over 5 years — worth asking whether the growth reaches owners. The cash-flow models don't apply cleanly here — the ledger says why below.Whether it’s worth owning at today’s price is the last question — and yours to answer, below.
| Figure | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|
| Revenue | $22,0001 | $14,0001 | $442,0002 | $420,0003 | $819,0003 |
| Net income | −$25.1M4 | −$26.9M5 | −$70.6M6 | −$16.6M7 | −$17.2M7 |
| Operating cash flow | −$27.6M8 | −$22.6M9 | −$20.6M10 | −$9.27M11 | −$8.3M11 |
| Capital expenditure | $265,00012 | $17,00013 | $76,00014 | $67,00015 | $17,00015 |
| Free cash flow (derived) | −$27.9M8 | −$22.6M9 | −$20.7M10 | −$9.34M11 | −$8.31M11 |
| Total debt | — | — | — | — | $3.08M16 |
| Cash & equivalents | $15M17 | $15.9M17 | $3.57M18 | $2.87M19 | $88,00019 |
| Diluted shares | 101,000 | 1.0M | 549,507 | 171,774 | 1.1M |
Superscripts are receipts. Each links to the SEC filing the number came from (full list at the bottom).
10 shares is a claim on $65.28 of net worth that earned you −$159.01 and generated −$76.93 of cash last year, against $28.48 of debt.
It earned an average -197% on invested capital over 5 years. Compare that to what it costs to fund the business.
seeing a moat in the numbers →Share count is up 970% over 5 years — owners have been diluted. Worth asking what they got for it. Total debt has held roughly steady.
reading capital allocation →Signals, not verdicts — read from the filings above. Numbers don’t prove a moat; they show its footprint. You decide.
Different models answer different questions — which to trust when →
- 10-K · period ending 2021-12-31 · accession 0001564590-23-004567 (RevenueFromContractWithCustomerExcludingAssessedTax)
- 10-K · period ending 2023-12-31 · accession 0001437749-25-009918 (RevenueFromContractWithCustomerExcludingAssessedTax)
- 10-K · period ending 2024-12-31 · accession 0001437749-26-010549 (RevenueFromContractWithCustomerExcludingAssessedTax)
- 10-K · period ending 2021-12-31 · accession 0001564590-23-004567 (NetIncomeLoss)
- 10-K · period ending 2022-12-31 · accession 0001654954-24-003964 (NetIncomeLoss)
- 10-K · period ending 2023-12-31 · accession 0001437749-25-009918 (NetIncomeLoss)
- 10-K · period ending 2024-12-31 · accession 0001437749-26-010549 (NetIncomeLoss)
- 10-K · period ending 2021-12-31 · accession 0001564590-23-004567 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2022-12-31 · accession 0001654954-24-003964 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2023-12-31 · accession 0001437749-25-009918 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2024-12-31 · accession 0001437749-26-010549 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2021-12-31 · accession 0001564590-23-004567 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2022-12-31 · accession 0001654954-24-003964 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2023-12-31 · accession 0001437749-25-009918 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2024-12-31 · accession 0001437749-26-010549 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2025-12-31 · accession 0001437749-26-010549 (LongTermDebt)
- 10-K · period ending 2021-12-31 · accession 0001564590-23-004567 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2023-12-31 · accession 0001437749-25-009918 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2024-12-31 · accession 0001437749-26-010549 (CashAndCashEquivalentsAtCarryingValue)